Berkeley Capital Partners’s Gilead Sciences GILD Stock Holding History

Berkeley Capital Partners’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$286K	Buy	2,053 +46	+2%	+$6.44K	0.07%	153
2025 Q4	$246K	Sell	2,007 -16	-0.8%	-$1.94K	0.06%	171
2025 Q3	$225K	Buy	2,023 +139	+7%	+$15.8K	0.05%	169
2025 Q2	$209K	Buy	1,884 +5	+0.3%	+$532	0.05%	164
2025 Q1	$211K	Buy	+1,879	New	+$194K	0.06%	162
2020 Q3	–	Sell	-7,545	Closed	-$580K	–	108
2020 Q2	$580K	Sell	7,545 -3,132	-29%	-$240K	0.36%	48
2020 Q1	$798K	Buy	+10,677	New	+$738K	0.54%	36
2016 Q1	–	Sell	-2,954	Closed	-$299K	–	115
2015 Q4	$299K	Buy	+2,954	New	+$307K	0.24%	80

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Berkeley Capital Partners's GILD Position: Q1 2026 in Review

Berkeley Capital Partners increased its Gilead Sciences (GILD) stake by 2.3% in Q1 2026, buying an estimated $6.44K and bringing the position to 2,053 shares worth $286K. The position accounts for 0.07% of the portfolio, ranked #153.

Berkeley Capital Partners first reported a position in GILD in Q4 2015 and has held it in 8 quarters since. The position peaked at $798K in Q1 2020. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

Berkeley Capital Partners held 2,053 shares of Gilead Sciences worth $286K as of Q1 2026.
Berkeley Capital Partners bought 46 Gilead Sciences shares in Q1 2026, an estimated $6.44K.
Gilead Sciences made up 0.07% of Berkeley Capital Partners's portfolio in Q1 2026, its #153 holding.
Berkeley Capital Partners first reported a position in Gilead Sciences in Q4 2015 and has held it in 8 quarters since.
Berkeley Capital Partners's Gilead Sciences position peaked at $798K in Q1 2020.
2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Berkeley Capital Partners's 13F filing for Q1 2026, filed 7 May 2026.